FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

No Safety Issues in Biosimilar Switches: Study

FDA researchers say they found no difference in safety when patients were switched between interchangeable biosimilars and the reference biologic.

latest-news-card-1
Human Drugs

Objectionable Conditions at Florida Doctor Site

FDA warns Atlantis, FL-based Dr. Luis Pena-Hernandez about objectionable conditions in his work conducting a clinical investigation.

latest-news-card-1
Human Drugs

Biomic Sciences Recalls Contaminated Sprays

Biomic Sciences recalls all lots of ION Sinus Support, ION Biome Sinus, and Restore Sinus Spray products due to microbial contamination concerns.

latest-news-card-1
Medical Devices

Attorney Blasts CDRH for 8,000-day Petition Delays

Attorney and data scientist Bradley Thompson blasts CDRH for its lengthy delays of up to 8,000 days in answering an average of 13 citizen petitions a ...

latest-news-card-1
Federal Register

User Fee Courier Delivery Address Change

Federal Register notice: FDA provides notice that the courier address used for user fee payments has changed effective 10/6.

latest-news-card-1
Federal Register

BD Vacutainers EUA Revoked

Federal Register notice: FDA announces that it revoked the Emergency Use Authorization issued to Becton, Dickinson for the BD Vacutainer Plus Citrate ...

latest-news-card-1
Federal Register

Ultram Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Janssen Pharmaceuticals Ultram (tramadol hydrochloride) tablets, 50 mg, was not withdrawn from sale for s...

Biologics

Moderna Phase 3 Trial for Flu/Covid Vaccine

Moderna says it will start a Phase 3 trial of its investigational mRNA-1083 combination flu/Covid vaccine later this year.

latest-news-card-1
Federal Register

Proposed Rule on Lab-developed Tests

Federal Register notice: FDA proposes to amend its regulations to make explicit that in vitro diagnostic products (IVDs) are devices under the Federal...

latest-news-card-1
Biologics

Signature Biologics Illegally Marketing Cord Product

FDA warns Irving, TX-based Signature Biologics that it is illegally marketing its human umbilical cord product that is manufactured with CGMP deviatio...